BOLD·10170A100·US·equity·Healthcare - Biotechnology-13D/G
BOLD (BOUNDLESS BIO INC) is held by 20 institutional investors as of Q1 2026. Largest holders: FMR LLC ($3M), CITADEL ADVISORS LLC ($1.5M), WELLINGTON MANAGEMENT GROUP LLP ($611,856). Net institutional sentiment: Mixed.
See how BOLD's score breaks down across 4 SEC sources
Showing 1-20 of 24
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer